Pax6 haploinsufficiency causes abnormal metabolic homeostasis by down-regulating glucagon-like peptide 1 in mice

Endocrinology

Volumn 150, Issue 5, 2009, Pages 2136-2144

  Ding, Jun ^a   Gao, Yan ^a   Zhao, Jing ^a   Yan, Hong ^a   Guo, Shi Ying ^a   Zhang, Qin Xian ^b   Li, Ng Song ^c   Gao, Xiang ^b,d  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b ZHENGZHOU UNIVERSITY   (China)

^c PEKING UNIVERSITY   (China)

^d NANJING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EXENDIN 4; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; HUMAN INSULIN; PROGLUCAGON; TRANSCRIPTION FACTOR PAX6; EYE PROTEIN; HOMEODOMAIN PROTEIN; PAIRED BOX TRANSCRIPTION FACTOR; REPRESSOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; ENERGY EXPENDITURE; FECES ANALYSIS; FOOD INTAKE; GLUCOSE INTAKE; HETEROZYGOSITY; HOMEOSTASIS; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; MALE; METABOLIC DISORDER; MOUSE; NEWBORN; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; AGE; ANIMAL; ANIMAL EMBRYO; C57BL MOUSE; GENE EXPRESSION REGULATION; GENETICS; HETEROZYGOSITY LOSS; METABOLISM; ORGAN SIZE; PANCREAS ISLET; PATHOLOGY; PHYSIOLOGY; TRANSGENIC MOUSE;

AGE FACTORS; ANIMALS; DOWN-REGULATION; EMBRYO, MAMMALIAN; EYE PROTEINS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GLUCAGON-LIKE PEPTIDE 1; HOMEODOMAIN PROTEINS; HOMEOSTASIS; ISLETS OF LANGERHANS; LOSS OF HETEROZYGOSITY; MALE; METABOLIC DISEASES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; ORGAN SIZE; PAIRED BOX TRANSCRIPTION FACTORS; REPRESSOR PROTEINS;

EID: 66449112884     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2008-1006     Document Type: Article

References (39)

1. Bopp D, Burri M, Baumgartner S, Frigerio G, Noll M 1986 Conservation of a large protein domain in the segmentation gene paired and in functionally related genes of Drosophila. Cell 47:1033-1040
2. Ashery-Padan R, Zhou X, Marquardt T, Herrera P, Toube L, Berry A, Gruss P 2004 Conditional inactivation of Pax6 in the pancreas causes early onset of diabetes. Dev Biol 269:479-488
3. Yasuda T, Kajimoto Y, Fujitani Y, Watada H, Yamamoto S, Watarai T, Umayahara Y, Matsuhisa M, Gorogawa S, Kuwayama Y, Tano Y, Yamasaki Y, Hori M 2002 PAX6 mutation as a genetic factor common to aniridia and glucose intolerance. Diabetes 51:224-230
4. Sander M, Neubuser A, Kalamaras J, Ee HC, Martin GR, German MS 1997 Genetic analysis reveals that PAX6 is required for normal transcription of pancreatic hormone genes and islet development. Genes Dev 11:1662-1673
5. St-Onge L, Sosa-Pineda B, Chowdhury K, Mansouri A, Gruss P 1997 Pax6 is required for differentiation of glucagon-producing α-cells in mouse pancreas. Nature 387:406-409
6. Hill ME, Asa SL, Drucker DJ 1999 Essential requirement for Pax6 in control of enteroendocrine proglucagon gene transcription. Mol Endocrinol 13:1474-1486
7. Mojsov S, Weir GC, Habener JF 1987 Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas. J Clin Invest 79:616-619
8. Drucker DJ 2007 The role of gut hormones in glucose homeostasis. J Clin Invest 117:24-32
9. Kjems LL, Holst JJ, Volund A, Madsbad S 2003 The influence of GLP-1 on glucose-stimulated insulin secretion: effects on β-cell sensitivity in type 2 and nondiabetic subjects. Diabetes 52:380-386
10. Lugari R, Dei Cas A, Ugolotti D, Finardi L, Barilli AL, Ognibene C, Luciani A, Zandomeneghi R, Gnudi A 2002 Evidence for early impairment of gluca- gon-like peptide 1-induced insulin secretion in human type 2 (non insulin- dependent) diabetes. Horm Metab Res 34:150-154
11. Valverde I, Wang GS, Burghardt K, Kauri LM, Redondo A, Acitores A, Villanueva-Penacarrillo ML, Courtois P, Sener A, Cancelas J, Malaisse WJ, Scott FW 2004 Bioactive GLP-1 in gut, receptor expression in pancreas, and insulin response to GLP-1 in diabetes-prone rats. Endocrine 23:77-84
12. Scrocchi LA, Brown TJ, MaClusky N, Brubaker PL, Auerbach AB, Joyner AL, Drucker DJ 1996 Glucose intolerance but normal satiety in mice with a null mutationin theglucagon-likepeptide1 receptor gene. Nat Med 2:1254-1258
13. Wang Q, Brubaker PL 2002 Glucagon-like peptide-1 treatment delays the onset of diabetes in 8 week-old db/db mice. Diabetologia 45:1263-1273
14. Deacon CF 2004 Therapeutic strategies based on glucagon-like peptide 1. Diabetes 53:2181-2189
15. He F WZ, Zhao J, Bao J, Ding J, Ruan HB, Xie Q, Zhang ZM, Gao X 2003 Large-scale screening of disease model through ENU mutagenesis in mice. Chin Sci Bull 48:2665-2671
16. Ruan HB, Zhang N, Gao X 2005 Identification of a novel point mutation of mouse proto-oncogene c-kit through N-ethyl-N-nitrosourea mutagenesis. Genetics 169:819-831
17. Jayasooriya AP, Mathai ML, Walker LL, Begg DP, Denton DA, Cameron-SmithD, EganGF, McKinleyMJ, RodgerPD, SinclairAJ, WarkJD, Weisinger HS, Jois M, Weisinger RS 2008 Mice lacking angiotensin-converting enzyme have increased energy expenditure, with reduced fat mass and improved glucose clearance. Proc Natl Acad Sci USA 105:6531-6536
18. Kitamura T, Kido Y, Nef S, Merenmies J, Parada LF, Accili D 2001 Preserved pancreatic (-cell development and function in mice lacking the insulin receptor-related receptor. Mol Cell Biol 21:5624-5630
19. Halatchev IG, Ellacott KL, Fan W, Cone RD 2004 Peptide YY3-36 inhibits food intake in mice through a melanocortin-4 receptor-independent mechanism. Endocrinology 145:2585-2590
20. FavorJ, PetersH, HermannT, SchmahlW, ChatterjeeB, Neuhauser-KlausA, Sandulache R 2001 Molecular characterization of Pax6(2Neu) through Pax6(10Neu): an extension ofthe Pax6 allelic series and the identification of two possible hypomorph alleles in the mouse Mus musculus. Genetics 159: 1689 -1700
21. Hansotia T, Drucker DJ2005 GIP and GLP-1 as incretin hormones: lessons from single and double incretin receptor knockout mice. Regul Pept 128: 125-134
22. PedersonRA, SatkunarajahM, McIntoshCH, ScrocchiLA, FlamezD, Schuit F, Drucker DJ, Wheeler MB 1998 Enhanced glucose-dependent insulinotropic polypeptide secretion and insulinotropic action in glucagon-like peptide 1 receptor -/- mice. Diabetes 47:1046-1052
23. Hansotia T, Maida A, Flock G, Yamada Y, Tsukiyama K, Seino Y, Drucker DJ 2007 Extrapancreatic incretin receptors modulate glucose homeostasis, body weight, and energy expenditure. J Clin Invest 117:143-152
24. Baggio L, Kieffer TJ, Drucker DJ 2000 Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, regulates fasting glycemia and nonen- teral glucose clearance in mice. Endocrinology 141:3703-3709
25. PreitnerF, IbbersonM, FranklinI, BinnertC, PendeM, GjinovciA, Hansotia T, Drucker DJ, Wollheim C, Burcelin R, Thorens B 2004 Gluco-incretins control insulin secretion at multiple levels as revealed in mice lacking GLP-1 and GIP receptors. J Clin Invest 113:635-645
26. Guillam MT, Hummler E, Schaerer E, Yeh JI, Birnbaum MJ, Beermann F, Schmidt A, Deriaz N, Thorens B 1997 Early diabetes and abnormal postnatal pancreatic islet development in mice lacking Glut-2. Nat Genet 17:327-330
27. Burcelin R, Dolci W, Thorens B 2000 Glucose sensing by the hepatoportal sensor is GLUT2-dependent: in vivo analysis in GLUT2-null mice. Diabetes 49:1643-1648
28. Brissova M, Shiota M, NicholsonWE, GannonM, Knobel SM, PistonDW, Wright CV, Powers AC 2002 Reduction in pancreatic transcription factor PDX-1 impairs glucose-stimulated insulinsecretion. JBiolChem277:11225- 11232
29. Li Y, Cao X, Li LX, Brubaker PL, Edlund H, Drucker DJ 2005 (-Cell Pdx1 expression is essential for the glucoregulatory, proliferative, and cytoprotec- tive actions of glucagon-like peptide-1. Diabetes 54:482-491
30. Toft-Nielsen MB, Madsbad S, Holst JJ 1999 Continuous subcutaneous infusion of glucagon-like peptide 1 lowers plasma glucose and reduces appetite in type 2 diabetic patients. Diabetes Care 22:1137-1143
31. Meeran K, O'Shea D, Edwards CM, Turton MD, Heath MM, Gunn I, Abusnana S, Rossi M, Small CJ, Goldstone AP, Taylor GM, Sunter D, Steere J, Choi SJ, Ghatei MA, Bloom SR 1999 Repeated intracerebroventricular administration of glucagon-likepeptide-1-(7-36)amideorexendin-(9-39)altersbodyweightinthe rat. Endocrinology 140:244-250
32. Baggio LL, Huang Q, Brown TJ, Drucker DJ 2004 A recombinant human glucagon-like peptide(GLP)-1-albumin protein (albugon) mimics peptidergic activation of GLP-1 receptor-dependent pathways coupled with satiety, gastrointestinal motility, and glucose homeostasis. Diabetes 53:2492-2500
33. LovshinJ, EstallJ, YustaB, BrownTJ, DruckerDJ2001 Glucagon-likepeptide (GLP)- 2actioninthemurinecentralnervoussystemisenhancedbyelimination of GLP-1 receptor signaling. J Biol Chem 276:21489-21499
34. Baggio LL, Huang Q, Brown TJ, Drucker DJ 2004 Oxyntomodulin and glu- cagon-like peptide-1 differentially regulate murine food intake and energy expenditure. Gastroenterology 127:546 -558
35. Kahn SE, Prigeon RL, Schwartz RS, Fujimoto WY, Knopp RH, Brunzell JD, Porte Jr D 2001 Obesity, body fat distribution, insulin sensitivity and islet (-cell function asexplanationsfor metabolic diversity. JNutr 131:354S-360S
36. Fujita Y, Chui JW, King DS, Zhang T, Seufert J, Pownall S, Cheung AT, Kieffer TJ 2008 Pax6 and Pdx1 are required for production of glucose-dependent insulinotropic polypeptide in proglucagon-expressing L cells. Am J Physiol 295:E648-E657
37. Kuroda A, Kaneto H, Fujitani Y, Watada H, Nakatani Y, Kajimoto Y, Matsuhisa M, Yamasakai Y, Fujiwara M 2004 Mutation of the Pax6 gene causes impaired glucose-stimulated insulin secretion. Diabetologia 47:2039-2041
38. Hamasaki A, Yamada Y, Kurose T, Ban N, Nagashima K, Takahashi A, Fujimoto S, Shimono D, Fujiwara M, Toyokuni S, Seino Y, Inagaki N 2007 Adult pancreatic islets require differential pax6 gene dosage. Biochem Biophys Res Commun 353:40-46
39. Zhang C, Moriguchi T, Kajihara M, Esaki R, Harada A, Shimohata H, Oishi H, Hamada M, Morito N, Hasegawa K, Kudo T, Engel JD, Yamamoto M, Takahashi S 2005 MafA is a key regulator of glucose-stimulated insulin secretion. Mol Cell Biol 25:4969-4976